Who should have a bone density scan (DXA)?
DXA should be performed for:
- Amenorrhea for more than 6 months and under 45
- Hyperthyroidism or hyperparathyroidism
- Malabsorption conditions (including celiac disease)
- Chronic kidney or liver disease
- Rheumatoid arthritis
- Long-term glucocorticoid therapy (e.g. prednisolone ≥7.5 mg/day for 3+ months)
- Aromatase inhibitor therapy for hormone-sensitive breast cancer
DXA also recommended when:
- Low or normal body weight (BMI under 20–22)
- Limited mobility
- Current smoker
- More than 2 standard drinks per day
- Diabetes, malnutrition, or other bone-affecting conditions
Understanding your T-score
| T-score | What it means |
|---|---|
| −1.0 or above | Normal bone density |
| −1.0 to −2.5 | Osteopenia (low bone mass) |
| −2.5 or below | Osteoporosis |
Why −1.8 is a key threshold
Research from the NORA study found that a T-score of −1.8 or below was associated with a meaningful increase in short-term fracture risk in postmenopausal women aged 50+. One-third of all fractures and one-fifth of hip fractures occurred in women aged 50–64.
MHT and bone protection
The Women’s Health Initiative study provides compelling evidence: MHT reduced vertebral and non-vertebral fractures by 34% in a large, diverse group of women, regardless of baseline bone density, BMI, smoking status, history of falls, family history, or calcium intake.
Calcium, vitamin D & lifestyle
Nutrition for bones:
- Calcium: 1,000–1,200 mg/day through diet
- Vitamin D: levels above 50 nmol/L; 1,000–2,000 IU/day supplementation commonly recommended
- Magnesium: cofactor for calcium — nuts, seeds, legumes, dark chocolate
- Adequate protein for muscle and bone health
- Vegans: monitor zinc, calcium, vitamin D, and B12
Activity & habits:
- Weight-bearing exercise and balance training reduce both bone loss and fall risk
- Limit alcohol to fewer than 2 standard drinks per day
- Smoking cessation is essential — smoking significantly accelerates bone loss
Sources
- Davis SR, Taylor S, Hemachandra C, et al. The 2023 Practitioner's Toolkit for Managing Menopause. Climacteric. 2023;26(6):517–536.
- Women's Health Initiative (WHI) randomized trials of menopausal hormone therapy.
- NORA (National Osteoporosis Risk Assessment) study.